Approximately 10–20% of breast cancer patients who are diagnosed with TNBC lack expression of estrogen receptor, progesterone receptor, and human epidermal growth factor (HER2/neu) (Carey et al., 2006). This evidence concerns the gene ERBB2 and breast cancer.